SION
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. (SION) has 13 SEC Form 4 filings (62 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is Insider Booth Bruce with 8 filings. Insiders have net sold $45.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Michael Cloonan
- Employees:41
- HQ:Waltham, MA, US
- IPO:2025-02-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67.3M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 85,918 | $3.9M | Jul 9 | SEC ↗ | |
| Director | Sale | 85,918 | $3.9M | Jul 9 | SEC ↗ | |
Fitzpatrick JenniferFirst filing | Chief Legal Officer | Sale | 10,250 | $447K | Jul 7 | SEC ↗ |
| Director | Sale | 115,844 | $5.3M | Jul 2 | SEC ↗ | |
| Director | Sale | 115,844 | $5.3M | Jul 2 | SEC ↗ | |
| Director | Sale | 101 | $4K | May 30 | SEC ↗ | |
| Director | Sale | 101 | $4K | May 30 | SEC ↗ | |
Thompson Peter A.First filing | Director | Sale | 48,546 | $2.2M | May 11 | SEC ↗ |
Thompson Peter A.First filing | Director | Sale | 59,767 | $2.7M | May 11 | SEC ↗ |
Thompson Peter A.First filing | Director | Sale | 184,639 | $8.5M | May 11 | SEC ↗ |
| Director | Sale | 48,546 | $2.2M | May 11 | SEC ↗ | |
| Director | Sale | 59,767 | $2.7M | May 11 | SEC ↗ | |
| Director | Sale | 184,639 | $8.5M | May 11 | SEC ↗ | |
Cloonan MichaelFirst filing | President & CEO | Sale | 99,800 | $3.6M | Oct 22 | SEC ↗ |
| Insider | Sale | 88,878 | $3.0M | Oct 21 | SEC ↗ | |
| Insider | Sale | 169,260 | $5.5M | Oct 20 | SEC ↗ | |
| Insider | Sale | 61,124 | $2.0M | Oct 20 | SEC ↗ | |
| Insider | Sale | 55,985 | $1.8M | Oct 20 | SEC ↗ | |
Booth BruceFirst filing | Insider | Sale | 20,238 | $607K | Oct 15 | SEC ↗ |
Booth BruceFirst filing | Insider | Sale | 58,232 | $1.8M | Oct 15 | SEC ↗ |
Booth BruceFirst filing | Insider | Sale | 606 | $18K | Oct 15 | SEC ↗ |
Booth BruceFirst filing | Insider | Sale | 115,856 | $3.5M | Oct 15 | SEC ↗ |
Related companies
Sionna Therapeutics, Inc. is in the Healthcare sector.